Literature DB >> 15203985

DC preparations for therapy.

A M Rice1, K L Jones, D N J Hart.   

Abstract

This review describes and compares the different DC preparations currently under laboratory and clinical investigation as vehicles for cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203985     DOI: 10.1080/14653240410005285

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  1 in total

1.  CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R.

Authors:  You-Shun Zhang; Fang-Jun Yuan; Guo-Feng Jia; Ji-Fa Zhang; Li-Yi Hu; Ling Huang; Ju Wang; Zong-Qing Dai
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.